A review on various targeted anticancer therapies

Area of Science:

• Oncology
• Translational Medicine
• Pharmacology

Background:

• Targeted anticancer therapy (TAT) offers a personalized medicine approach distinct from conventional treatments.
• TAT utilizes drugs with specific mechanisms to target cancer pathways, minimizing harm to healthy tissues.
• Existing TAT approaches show promise for clinical applications in oncology.

Purpose of the Study:

• To review current promising targeted anticancer therapy (TAT) approaches.
• To introduce a novel small molecular sequential dual targeting theragnostic strategy for solid tumors.
• To enhance cancer treatability and curability through advanced therapeutic strategies.

Main Methods:

• Review of existing literature on targeted anticancer therapies.
• Development and conceptualization of a novel small molecular sequential dual targeting theragnostic strategy.
• Discussion of the potential application of this strategy in managing solid malignancies.

Main Results:

• Identified promising TAT approaches for personalized cancer medicine.
• Proposed a new generalized class of TAT: small molecular sequential dual targeting theragnostic strategy.
• Highlighted the potential for improved cancer treatability and curability.

Conclusions:

• Targeted anticancer therapies represent a significant advancement in oncology.
• The newly developed sequential dual targeting theragnostic strategy offers a promising generalized approach for solid tumors.
• Further optimization of this strategy is expected to improve patient outcomes in cancer management.